These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18435757)

  • 21. NMR as a tool for elucidating the structures of circular and knotted proteins.
    Craik DJ; Daly NL
    Mol Biosyst; 2007 Apr; 3(4):257-65. PubMed ID: 17372654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides.
    Gunasekera S; Foley FM; Clark RJ; Sando L; Fabri LJ; Craik DJ; Daly NL
    J Med Chem; 2008 Dec; 51(24):7697-704. PubMed ID: 19053834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
    Reinwarth M; Nasu D; Kolmar H; Avrutina O
    Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimalist active-site redesign: teaching old enzymes new tricks.
    Toscano MD; Woycechowsky KJ; Hilvert D
    Angew Chem Int Ed Engl; 2007; 46(18):3212-36. PubMed ID: 17450624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering of non-natural receptors.
    Mathonet P; Fastrez J
    Curr Opin Struct Biol; 2004 Aug; 14(4):505-11. PubMed ID: 15313246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding proteins from alternative scaffolds.
    Nygren PA; Skerra A
    J Immunol Methods; 2004 Jul; 290(1-2):3-28. PubMed ID: 15261569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacing antibodies: engineering new binding proteins.
    Banta S; Dooley K; Shur O
    Annu Rev Biomed Eng; 2013; 15():93-113. PubMed ID: 23642248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cyclotides and related macrocyclic peptides as scaffolds in drug design.
    Craik DJ; Cemazar M; Daly NL
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):251-60. PubMed ID: 16566295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface grafting onto template-assembled synthetic protein scaffolds in molecular recognition.
    Fernandez-Carneado J; Grell D; Durieux P; Hauert J; Kovacsovics T; Tuchscherer G
    Biopolymers; 2000; 55(6):451-8. PubMed ID: 11304672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein design through systematic catalytic loop exchange in the (beta/alpha)8 fold.
    Ochoa-Leyva A; Soberón X; Sánchez F; Argüello M; Montero-Morán G; Saab-Rincón G
    J Mol Biol; 2009 Apr; 387(4):949-64. PubMed ID: 19233201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein and cellular engineering with unnatural amino acids.
    Liao J
    Biotechnol Prog; 2007; 23(1):28-31. PubMed ID: 17269666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of phage-displayed cystine-stabilized mini-protein libraries for proteinaceous binder engineering.
    Chang HJ; Yang AS
    Methods Mol Biol; 2014; 1088():1-17. PubMed ID: 24146393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
    Ebersbach H; Fiedler E; Scheuermann T; Fiedler M; Stubbs MT; Reimann C; Proetzel G; Rudolph R; Fiedler U
    J Mol Biol; 2007 Sep; 372(1):172-85. PubMed ID: 17628592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.
    Moore SJ; Leung CL; Norton HK; Cochran JR
    PLoS One; 2013; 8(4):e60498. PubMed ID: 23573262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbodies.
    Schmoldt HU; Daneschdar M; Kolmar H; Blind M
    Methods Mol Biol; 2009; 535():361-72. PubMed ID: 19377985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating receptor flexibility in the molecular design of protein interfaces.
    Li L; Liang S; Pilcher MM; Meroueh SO
    Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.
    Backer MV; Levashova Z; Levenson R; Blankenberg FG; Backer JM
    Methods Mol Biol; 2008; 494():275-94. PubMed ID: 18726580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
    Werle M; Kafedjiiski K; Kolmar H; Bernkop-Schnürch A
    Int J Pharm; 2007 Mar; 332(1-2):72-9. PubMed ID: 17070661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of photoactive analogues of a cystine knot trypsin inhibitor protein.
    Durek T; Zhang J; He C; Kent SB
    Org Lett; 2007 Dec; 9(26):5497-500. PubMed ID: 18041846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.